JTCS Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Macmanus, Q.
Right arrow Articles by Starr, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Macmanus, Q.
Right arrow Articles by Starr, A.

The Journal of Thoracic and Cardiovascular Surgery, Vol 80, 834-841, Copyright © 1980 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Year of operation as a risk factor in the late results of valve replacement

Q Macmanus, GL Grunkemeier, LE Lambert, JF Teply, BJ Harlan and A Starr

The actuarial thromboembolic rates of aortic and mitral silicone ball valves used during the second decade of cardiac valve replacement are significantly lower than the rates for the same prostheses implanted during the first decade, as shown in the following table: (Formula: see text). The embolus-free rates are significantly different (p < 0.01) in both the mitral and aortic series. Five-year embolus-free rates for the composite-strut caged-ball, Bjork-Shiley tilting disc, and porcine xenograft valves all fall in the range of from 81% to 92% for the mitral position and from 91% to 97% for the aortic. Thus the standard silicone ball-valve prosthesis, used during the current era, has a thromboembolic risk as low as that reported with other concurrently utilized valve substitutes. This striking reduction in thrombogenicity demonstrates that the time frame of implantation must be considered when evaluating the results of cardiac valve replacement.


This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
M. Shiono, Y. Sezai, A. Sezai, M. Hata, M. Iida, and N. Negishi
Long-Term Results of the Cloth-Covered Starr-Edwards Ball Valve
Ann. Thorac. Surg., July 1, 2005; 80(1): 204 - 209.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
A. J. Murday, A. Hochstitzky, J. Mansfield, J. Miles, B. Taylor, E. Whitley, and T. Treasure
A prospective controlled trial of st. jude versus starr edwards aortic and mitral valve prostheses
Ann. Thorac. Surg., July 1, 2003; 76(1): 66 - 73.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
T. A. Orszulak, H. V. Schaff, F. J. Puga, G. K. Danielson, C. J. Mullany, B. J. Anderson, and D. M. Ilstrup
Event Status of the Starr-Edwards Aortic Valve to 20 Years: A Benchmark for Comparison
Ann. Thorac. Surg., March 1, 1997; 63(3): 620 - 626.
[Abstract] [Full Text]

Home page
 JAMAHome page
M. H. Eckman, J. R. Beshansky, I. Durand-Zaleski, H. J. Levine, and S. G. Pauker
Anticoagulation for Noncardiac Procedures in Patients With Prosthetic Heart Valves: Does Low Risk Mean High Cost?
JAMA, March 16, 1990; 263(11): 1513 - 1521.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1980 by The American Association for Thoracic Surgery.